Hikma Posts A Stellar H1 Performance, Re-affirms Expectations For Strong Growth In The Second Half
By Ron Chen, Bureau Chief, Asia Hikma Pharmaceuticals Plc and its subsidiaries Hikma, the multinational pharmaceutical company, has reported its...
archivepapillio
